Influenza A virus H5N1 internal proteins (H5N1 internal proteins)

Influenza A H5N1 internal proteins represent a collection of highly conserved viral components essential for the replication and structural integrity of the H5N1 avian influenza virus. This group includes the RNA-dependent RNA polymerase complex (PA, PB1, and PB2), the nucleoprotein (NP), the matrix proteins (M1 and M2), and the non-structural proteins (NS1 and NEP/NS2) [1][2]. Because these proteins exhibit significantly lower mutation rates compared to the surface glycoproteins hemagglutinin and neuraminidase, they are critical focal points for "universal" vaccine strategies aimed at eliciting cross-reactive T-cell responses [3]. Biologically, these proteins mediate viral genome replication, nuclear export, and the suppression of host antiviral signaling, such as the interferon response [4]. Clinically, the M2 ion channel and the PA subunit of the polymerase are established targets for FDA-approved antivirals like amantadine and baloxavir marboxil, respectively [5]. However, the emergence of widespread resistance to M2 inhibitors in H5N1 strains necessitates the ongoing development of novel inhibitors targeting the polymerase complex and nucleoprotein [6].

Other names

H5N1 core proteinsInfluenza A H5N1 conserved proteinsH5N1 internal antigensH5N1 viral internal proteins

Inhibition of the M2 ion channel to prevent viral uncoating; inhibition of the viral RNA-dependent RNA polymerase (RdRp) complex (PA, PB1, PB2) to block genome replication and transcription; and inhibition of nucleoprotein (NP) to prevent viral assembly.